2022
DOI: 10.1002/anbr.202100120
|View full text |Cite
|
Sign up to set email alerts
|

CD36‐Binding Amphiphilic Nanoparticles for Attenuation of α‐Synuclein‐Induced Microglial Activation

Abstract: Neuroinflammation is one of the hallmarks contributing to Parkinson's disease (PD) pathology, where microglial activation occurs as one of the earliest events, triggered by extracellular α‐synuclein (aSYN) binding to the cluster of differentation 36 (CD36) receptor. Herein, CD36‐binding nanoparticles (NPs) containing tartaric acid–based amphiphilic macromolecules (AMs) are rationally designed to inhibit this aSYN–CD36 binding. In silico docking reveals that four AMs with varying alkyl side chain lengths presen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(15 citation statements)
references
References 48 publications
0
13
0
Order By: Relevance
“…Amphiphilic macromolecule-based nanoparticles have been developed with a tunable binding affinity for CD36, a class B scavenger receptor that mediates microglial activation. 186 Optimization of the alkyl side chain length in the polymer core increased binding of the nanoparticles to CD36, inhibiting microglial interactions with a-synuclein aggregates, which are known to propagate inflammatory signaling in Parkinson's disease. 87,186 In another study, chitosan nanocarriers were modified with fucoidan, 187 a sulfated amphiphilic polysaccharide that is known to target P-selectin, 188 a cell adhesion molecule used to recruit macrophages to an inflammatory environment.…”
Section: Review Materials Advancesmentioning
confidence: 99%
See 3 more Smart Citations
“…Amphiphilic macromolecule-based nanoparticles have been developed with a tunable binding affinity for CD36, a class B scavenger receptor that mediates microglial activation. 186 Optimization of the alkyl side chain length in the polymer core increased binding of the nanoparticles to CD36, inhibiting microglial interactions with a-synuclein aggregates, which are known to propagate inflammatory signaling in Parkinson's disease. 87,186 In another study, chitosan nanocarriers were modified with fucoidan, 187 a sulfated amphiphilic polysaccharide that is known to target P-selectin, 188 a cell adhesion molecule used to recruit macrophages to an inflammatory environment.…”
Section: Review Materials Advancesmentioning
confidence: 99%
“…186 Optimization of the alkyl side chain length in the polymer core increased binding of the nanoparticles to CD36, inhibiting microglial interactions with a-synuclein aggregates, which are known to propagate inflammatory signaling in Parkinson's disease. 87,186 In another study, chitosan nanocarriers were modified with fucoidan, 187 a sulfated amphiphilic polysaccharide that is known to target P-selectin, 188 a cell adhesion molecule used to recruit macrophages to an inflammatory environment. 189,190 Chitosan is particularly responsive to acidic environments, promoting accumulation of chitosan nanoparticles in acidic inflammatory tissue sites.…”
Section: Review Materials Advancesmentioning
confidence: 99%
See 2 more Smart Citations
“…We have previously designed a new class of amphiphilic macromolecules (AMs) composed of sugar-based backbones, aliphatic side chains, and hydrophilic poly (ethylene glycol) (PEG); these were conceived to be biomimetic synthetic ligands for lowering the SR–α-synuclein (α-syn) interactions and the subsequent microglial inflammatory response [ 48 50 ]. Due to their amphiphilic nature, AMs can be complexed around hydrophobic core molecules via kinetic flash nanoprecipitation (FNP), forming nanoparticles (NPs).…”
Section: Introductionmentioning
confidence: 99%